COCH — Envoy Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $28.79m
- $42.02m
- $0.23m
Annual cashflow statement for Envoy Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -8.68 | -15.9 | -29.9 | -20.8 |
| Depreciation | ||||
| Non-Cash Items | 1.75 | 7.2 | 13.1 | 3.31 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.082 | -0.16 | -0.958 | -0.637 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -6.94 | -8.8 | -17.7 | -17.9 |
| Capital Expenditures | -0.125 | -0.218 | -0.153 | -0.98 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.125 | -0.218 | -0.153 | -0.98 |
| Financing Cash Flow Items | 0.058 | 0.092 | 11.7 | -0.916 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 8.06 | 8.09 | 21.8 | 20.2 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.987 | -0.938 | 4.04 | 1.26 |